Peptide Stack
Wolverine stack extended
A four-compound injury-recovery stack combining BPC-157, TB-500, GHK-Cu, and KPV. It is marketed for recovery-focused wellness protocols, but human evidence is limited and the stack is not FDA approved.
Detail
Overview
A four-compound injury-recovery stack combining BPC-157, TB-500, GHK-Cu, and KPV. It is marketed for recovery-focused wellness protocols, but human evidence is limited and the stack is not FDA approved.
Benefits, side effects, and protocols
Benefits list
Side effects
Vendor protocol
- Pre-blended 80 mg 5:1:1:1 KLOW-style vial; common daily dose 0.10 mL (~2.67 mg total blend)
Clinical protocol
- No standard clinical protocol; the four-compound stack remains investigational because human data are very limited
- TB-500/thymosin beta-4 is still mainly supported by preclinical and ocular wound-healing research rather than an established stack regimen
Evidence
- Low
- Informal multi-peptide recovery stack with limited human evidence
Regulatory
- Not Fda Approved
Research
Mechanisms
None Listed
Evidence notes
- Low
- Informal multi-peptide recovery stack with limited human evidence
Administration
Subcutaneous
Research links
- None listed
Contraindications
- None listed
Regulatory data
- Not Fda Approved
Aliases
- wolverine stack 4-compound
- wolverine stack extended
- wolverine blend
Related compounds
Educational reference only. Pepperz does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing recommendations. Sourcing Wolverine stack extended? Check your source before you use anything.